Nomura Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,872
Closed -$405K 1538
2025
Q2
$405K Buy
+5,872
New +$399K ﹤0.01% 825
2025
Q1
Sell
-43,776
Closed -$3.62M 1569
2024
Q4
$3.77M Buy
43,776
+23,238
+113% +$2.51M 0.01% 632
2024
Q3
$2.45M Hold
20,538
0.01% 716
2024
Q2
$2.93M Hold
20,538
0.01% 653
2024
Q1
$2.64M Hold
20,538
0.01% 677
2023
Q4
$2.12M Sell
20,538
-4,442
-18% -$439K 0.01% 706
2023
Q3
$2.27M Buy
24,980
+4,228
+20% +$372K 0.01% 679
2023
Q2
$1.68M Buy
20,752
+6,474
+45% +$529K 0.01% 735
2023
Q1
$1.14M Hold
14,278
0.01% 787
2022
Q4
$966K Sell
14,278
-8,018
-36% -$470K 0.01% 810
2022
Q3
$1.11M Hold
22,296
0.01% 778
2022
Q2
$1.24M Hold
22,296
0.01% 790
2022
Q1
$1.24M Buy
22,296
+7,866
+55% +$404K 0.01% 809
2021
Q4
$808K Buy
+14,430
New +$782K ﹤0.01% 873

Other funds holding NVO

Nomura Asset Management's NVO Position: Q3 2025 in Review

Nomura Asset Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 5,872 shares — an estimated $405K sold.

Nomura Asset Management first reported a position in NVO in Q4 2021 and held it in 14 quarters. The position peaked at $3.77M in Q4 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Nomura Asset Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Nomura Asset Management sold 5,872 Novo Nordisk shares in Q3 2025, an estimated $405K.
  • Nomura Asset Management first reported a position in Novo Nordisk in Q4 2021 and held it in 14 quarters.
  • Nomura Asset Management's Novo Nordisk position peaked at $3.77M in Q4 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Nomura Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.